To determine if JNK-IN-8 sensitizes breast cancer cell lines to lapatinib, cell viability was measured in the presence of either vehicle alone, JNK-IN-8 alone, lapatinib alone, or JNK-IN-8 with lapatinib. Here, MAPK8 is linked to breast carcinoma.